EPO Patents = 1

Trademarks = 4

Forward Citations = 2

Loading Chart...

16 inventors (with patents filed for the assignee):

Jongjin Park (4 out of 9 patents)

Sunghwa Choe (4 out of 12 patents)

Dong Wook Kim (4 out of 70 patents)

4. Aiden Y Park (3 out of 3 patents)

5. Sungyong In (2 out of 6 patents)

6. Jung Hak Lim (2 out of 2 patents)

7. Ji Young Yoon (2 out of 2 patents)

8. Mi Jin Park (2 out of 2 patents)

9. Sunmee Choi (1 out of 1 patent)

10. Mijin Park (1 out of 10 patents)

11. Slki Park (1 out of 1 patent)

12. Junghak Lim (1 out of 1 patent)

13. Youngdong Yoo (1 out of 1 patent)

14. Jung Hyuk Lee (1 out of 2 patents)

15. Han Seong Kim (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 11865164 - Pharmaceutical composition for treating cancer, containing guide RNA and endonuclease as active ingredients (2024-01-09),

2. 11491208 - Sequence-specific in vivo cell targeting (2022-11-08),

3. 11434478 - Compositions and methods for genome engineering with Cas12a proteins (2022-09-06),

4. 11293019 - Chimeric genome engineering molecules and methods (2022-04-05),

Gflas Life Sciences, Inc. is a leading biotechnology company dedicated to revolutionizing healthcare through innovative research and development. Our cutting-edge platforms enable us to discover and develop novel therapeutics for various diseases. With a focus on precision medicine, we aim to improve patient outcomes and quality of life. Visit our website to learn more about our groundbreaking work.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

4 Patents

#674 in Seoul

#2,085 in South Korea

Seoul, South Korea

Gflas Life Sciences, Inc.